Notably, tumors with VPS72 copy number gain (>median expression) and ATF3 loss (<median expression) exhibited heightened mTORC1 activation, suggesting that mTORC1 signaling is a downstream target of VPS72 amplification in liver cancer (Figure 5N). This evidence concerns the gene ATF3 and liver cancer.